The rhinoplasty implants market is projected to observe lucrative growth over 2021-2027 due to the increasing beauty consciousness and improving affordability of cosmetic surgeries. These is a gradual rise in demand for cosmetic procedures among people to improve their facial features, which has led to a boom in the cosmetic surgery sector.

The COVID-19 pandemic has seemingly fueled virtual living in the wake of the ???work from home??? culture. It made video-conferencing a primary means of communication both for work as well as social events. Prevalent body dissatisfaction due to increasing time spent in video calls can give rise to the global phenomenon dubbed ???Zoom dysmorphia???.

Experts say that non-surgical rhinoplasty procedures can effectively hide minor imperfections, such as camouflage a bump, add dorsal height, and make the nose narrower. On the other hand, surgical procedures are preferred for fixing functional nasal issues like a deviated septum. Moreover, age-related changes can cause the nose to appear bigger or wider, which is a key factor boosting the demand for rhinoplasty surgery among adults in the 30-50 age group.

A surging focus on cosmetic procedures to improve the appearance or functionality of the nose is expected to fuel rhinoplasty implants market size in the coming years. For an all-inclusive assessment, the market is bifurcated based on procedure, gender, end-use, and region.

On the basis of procedure, the industry has further been segregated into surgical and non-surgical. In 2020, the non-surgical segment was valued at over USD 480 million and is expected to grow at a CAGR of 16.1% up to 2027. Better availability of dermal fillers, coupled with high efficacy is offering improved outcomes, which is projected to boost the adoption of non-surgical implants.

In terms of gender, the rhinoplasty implants market has been divided into female and male. The female sub-segment valuation exceeded USD 585 million in 2020 and is estimated to register a CAGR of 16.1% through the analysis period. Rising awareness pertaining to nose reshaping procedures is speculated to primarily drive segmental growth over the next few years.

The end-users of rhinoplasty implants are hospitals, ambulatory surgical centers, and others. During 2020, the ambulatory surgical centers end-use segment was valued at USD 291 million and is anticipated to expand at a CAGR of 15.9% through 2027. Rising technological developments in aesthetic procedures, along with their enhanced cost effectiveness, are projected to drive customers visits to ASCs.

In the regional spectrum, the Middle East & Africa rhinoplasty implants market valuation surpassed USD 39 million in 2020. The regional market is projected to witness sizable growth a CAGR of 14.4% through the coming years owing to expanding beauty conscious population across several countries.